121 related articles for article (PubMed ID: 33493533)
1. SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.
Santharam MA; Shukla A; Ihsan AU; Cloutier M; Levesque D; Ramanathan S; Boisvert FM; Ilangumaran S
Biochimie; 2021 Mar; 182():185-196. PubMed ID: 33493533
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
4. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
5. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.
Gui Y; Yeganeh M; Cepero-Donates Y; Ramanathan S; Saucier C; Ilangumaran S
Curr Pharm Des; 2014; 20(17):2922-33. PubMed ID: 23944359
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis.
Saint-Germain E; Mignacca L; Huot G; Acevedo M; Moineau-Vallée K; Calabrese V; Bourdeau V; Rowell MC; Ilangumaran S; Lessard F; Ferbeyre G
Cancer Res; 2019 Jul; 79(13):3306-3319. PubMed ID: 31101761
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
9. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes.
Gui Y; Yeganeh M; Ramanathan S; Leblanc C; Pomerleau V; Ferbeyre G; Saucier C; Ilangumaran S
J Hepatol; 2011 Dec; 55(6):1300-8. PubMed ID: 21703184
[TBL] [Abstract][Full Text] [Related]
10. The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo.
Doggett K; Keating N; Dehkhoda F; Bidgood GM; Meza Guzman LG; Leong E; Kueh A; Nicola NA; Kershaw NJ; Babon JJ; Alexander WS; Nicholson SE
Cytokine; 2023 May; 165():156167. PubMed ID: 36934508
[TBL] [Abstract][Full Text] [Related]
11. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.
McCormick SM; Gowda N; Fang JX; Heller NM
J Biol Chem; 2016 Sep; 291(39):20574-87. PubMed ID: 27507812
[TBL] [Abstract][Full Text] [Related]
13. Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination.
Chen H; Wu Y; Li K; Currie I; Keating N; Dehkhoda F; Grohmann C; Babon JJ; Nicholson SE; Sleebs BE
ACS Chem Biol; 2022 Feb; 17(2):449-462. PubMed ID: 34989544
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation.
De Sepulveda P; Ilangumaran S; Rottapel R
J Biol Chem; 2000 May; 275(19):14005-8. PubMed ID: 10747851
[TBL] [Abstract][Full Text] [Related]
15. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation.
He Y; Zhang W; Zhang R; Zhang H; Min W
J Biol Chem; 2006 Mar; 281(9):5559-66. PubMed ID: 16407264
[TBL] [Abstract][Full Text] [Related]
16. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.
De Sepulveda P; Okkenhaug K; Rose JL; Hawley RG; Dubreuil P; Rottapel R
EMBO J; 1999 Feb; 18(4):904-15. PubMed ID: 10022833
[TBL] [Abstract][Full Text] [Related]
17. KIAA0317 regulates SOCS1 stability to ameliorate colonic inflammation.
Lockwood KC; Lear TB; Rajbhandari S; McKelvey AC; Dunn SR; Boudreau ÁN; Liu Y; Chen BB
FEBS J; 2023 Aug; 290(15):3802-3811. PubMed ID: 36938956
[TBL] [Abstract][Full Text] [Related]
18. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.
Kamizono S; Hanada T; Yasukawa H; Minoguchi S; Kato R; Minoguchi M; Hattori K; Hatakeyama S; Yada M; Morita S; Kitamura T; Kato H; Nakayama Ki ; Yoshimura A
J Biol Chem; 2001 Apr; 276(16):12530-8. PubMed ID: 11278610
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus.
Strebovsky J; Walker P; Lang R; Dalpke AH
FASEB J; 2011 Mar; 25(3):863-74. PubMed ID: 21084693
[TBL] [Abstract][Full Text] [Related]
20. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
